Global Female Contraceptives Market Growth (Status and Outlook) 2022-2028
- LP 4925279
- 103 Pages
- March 2022
- Pharmaceuticals
The United States Female Contraceptives market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Female Contraceptives market, reaching US$ million by the year 2028. As for the Europe Female Contraceptives landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Female Contraceptives players cover Bayer, Mayer Laboratories, Pfizer, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraceptives market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Contraceptive Drugs
Contraceptive Devices
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Personal use
Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Female Contraceptives Market Size 2017-2028
2.1.2 Female Contraceptives Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Female Contraceptives Segment by Type
2.2.1 Contraceptive Drugs
2.2.2 Contraceptive Devices
2.3 Female Contraceptives Market Size by Type
2.3.1 Female Contraceptives Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Female Contraceptives Market Size Market Share by Type (2017-2022)
2.4 Female Contraceptives Segment by Application
2.4.1 Personal use
2.4.2 Hospital
2.5 Female Contraceptives Market Size by Application
2.5.1 Female Contraceptives Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Female Contraceptives Market Size Market Share by Application (2017-2022)
3 Female Contraceptives Market Size by Player
3.1 Female Contraceptives Market Size Market Share by Players
3.1.1 Global Female Contraceptives Revenue by Players (2020-2022)
3.1.2 Global Female Contraceptives Revenue Market Share by Players (2020-2022)
3.2 Global Female Contraceptives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Female Contraceptives by Regions
4.1 Female Contraceptives Market Size by Regions (2017-2022)
4.2 Americas Female Contraceptives Market Size Growth (2017-2022)
4.3 APAC Female Contraceptives Market Size Growth (2017-2022)
4.4 Europe Female Contraceptives Market Size Growth (2017-2022)
4.5 Middle East & Africa Female Contraceptives Market Size Growth (2017-2022)
5 Americas
5.1 Americas Female Contraceptives Market Size by Country (2017-2022)
5.2 Americas Female Contraceptives Market Size by Type (2017-2022)
5.3 Americas Female Contraceptives Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Contraceptives Market Size by Region (2017-2022)
6.2 APAC Female Contraceptives Market Size by Type (2017-2022)
6.3 APAC Female Contraceptives Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Female Contraceptives by Country (2017-2022)
7.2 Europe Female Contraceptives Market Size by Type (2017-2022)
7.3 Europe Female Contraceptives Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Female Contraceptives by Region (2017-2022)
8.2 Middle East & Africa Female Contraceptives Market Size by Type (2017-2022)
8.3 Middle East & Africa Female Contraceptives Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Female Contraceptives Market Forecast
10.1 Global Female Contraceptives Forecast by Regions (2023-2028)
10.1.1 Global Female Contraceptives Forecast by Regions (2023-2028)
10.1.2 Americas Female Contraceptives Forecast
10.1.3 APAC Female Contraceptives Forecast
10.1.4 Europe Female Contraceptives Forecast
10.1.5 Middle East & Africa Female Contraceptives Forecast
10.2 Americas Female Contraceptives Forecast by Country (2023-2028)
10.2.1 United States Female Contraceptives Market Forecast
10.2.2 Canada Female Contraceptives Market Forecast
10.2.3 Mexico Female Contraceptives Market Forecast
10.2.4 Brazil Female Contraceptives Market Forecast
10.3 APAC Female Contraceptives Forecast by Region (2023-2028)
10.3.1 China Female Contraceptives Market Forecast
10.3.2 Japan Female Contraceptives Market Forecast
10.3.3 Korea Female Contraceptives Market Forecast
10.3.4 Southeast Asia Female Contraceptives Market Forecast
10.3.5 India Female Contraceptives Market Forecast
10.3.6 Australia Female Contraceptives Market Forecast
10.4 Europe Female Contraceptives Forecast by Country (2023-2028)
10.4.1 Germany Female Contraceptives Market Forecast
10.4.2 France Female Contraceptives Market Forecast
10.4.3 UK Female Contraceptives Market Forecast
10.4.4 Italy Female Contraceptives Market Forecast
10.4.5 Russia Female Contraceptives Market Forecast
10.5 Middle East & Africa Female Contraceptives Forecast by Region (2023-2028)
10.5.1 Egypt Female Contraceptives Market Forecast
10.5.2 South Africa Female Contraceptives Market Forecast
10.5.3 Israel Female Contraceptives Market Forecast
10.5.4 Turkey Female Contraceptives Market Forecast
10.5.5 GCC Countries Female Contraceptives Market Forecast
10.6 Global Female Contraceptives Forecast by Type (2023-2028)
10.7 Global Female Contraceptives Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Female Contraceptives Product Offered
11.1.3 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Mayer Laboratories
11.2.1 Mayer Laboratories Company Information
11.2.2 Mayer Laboratories Female Contraceptives Product Offered
11.2.3 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Mayer Laboratories Main Business Overview
11.2.5 Mayer Laboratories Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Female Contraceptives Product Offered
11.3.3 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Female Contraceptives Product Offered
11.4.3 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Mylan Main Business Overview
11.4.5 Mylan Latest Developments
11.5 Teva
11.5.1 Teva Company Information
11.5.2 Teva Female Contraceptives Product Offered
11.5.3 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Teva Main Business Overview
11.5.5 Teva Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Female Contraceptives Product Offered
11.6.3 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Female Contraceptives Product Offered
11.7.3 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Information
11.8.2 Lupin Pharmaceuticals Female Contraceptives Product Offered
11.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Lupin Pharmaceuticals Main Business Overview
11.8.5 Lupin Pharmaceuticals Latest Developments
11.9 Female Health Company
11.9.1 Female Health Company Company Information
11.9.2 Female Health Company Female Contraceptives Product Offered
11.9.3 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Female Health Company Main Business Overview
11.9.5 Female Health Company Latest Developments
11.10 Fuji Latex
11.10.1 Fuji Latex Company Information
11.10.2 Fuji Latex Female Contraceptives Product Offered
11.10.3 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Fuji Latex Main Business Overview
11.10.5 Fuji Latex Latest Developments
12 Research Findings and Conclusion
Table 1. Female Contraceptives Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Contraceptive Drugs
Table 3. Major Players of Contraceptive Devices
Table 4. Female Contraceptives Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Female Contraceptives Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Female Contraceptives Market Size Market Share by Type (2017-2022)
Table 7. Female Contraceptives Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Female Contraceptives Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Female Contraceptives Market Size Market Share by Application (2017-2022)
Table 10. Global Female Contraceptives Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Female Contraceptives Revenue Market Share by Player (2020-2022)
Table 12. Female Contraceptives Key Players Head office and Products Offered
Table 13. Female Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Female Contraceptives Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Female Contraceptives Market Size Market Share by Regions (2017-2022)
Table 18. Americas Female Contraceptives Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Female Contraceptives Market Size Market Share by Country (2017-2022)
Table 20. Americas Female Contraceptives Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Female Contraceptives Market Size Market Share by Type (2017-2022)
Table 22. Americas Female Contraceptives Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Female Contraceptives Market Size Market Share by Application (2017-2022)
Table 24. APAC Female Contraceptives Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Female Contraceptives Market Size Market Share by Region (2017-2022)
Table 26. APAC Female Contraceptives Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Female Contraceptives Market Size Market Share by Type (2017-2022)
Table 28. APAC Female Contraceptives Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Female Contraceptives Market Size Market Share by Application (2017-2022)
Table 30. Europe Female Contraceptives Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Female Contraceptives Market Size Market Share by Country (2017-2022)
Table 32. Europe Female Contraceptives Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Female Contraceptives Market Size Market Share by Type (2017-2022)
Table 34. Europe Female Contraceptives Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Female Contraceptives Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Female Contraceptives Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Female Contraceptives Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Female Contraceptives Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Female Contraceptives Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Female Contraceptives Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Female Contraceptives Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Female Contraceptives
Table 43. Key Market Challenges & Risks of Female Contraceptives
Table 44. Key Industry Trends of Female Contraceptives
Table 45. Global Female Contraceptives Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Female Contraceptives Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Female Contraceptives Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Female Contraceptives Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Female Contraceptives Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Female Contraceptives Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bayer Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 52. Bayer Female Contraceptives Product Offered
Table 53. Bayer Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Mayer Laboratories Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 57. Mayer Laboratories Female Contraceptives Product Offered
Table 58. Mayer Laboratories Main Business
Table 59. Mayer Laboratories Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Mayer Laboratories Latest Developments
Table 61. Pfizer Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 62. Pfizer Female Contraceptives Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Mylan Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 67. Mylan Female Contraceptives Product Offered
Table 68. Mylan Main Business
Table 69. Mylan Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Mylan Latest Developments
Table 71. Teva Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 72. Teva Female Contraceptives Product Offered
Table 73. Teva Main Business
Table 74. Teva Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Teva Latest Developments
Table 76. Merck Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 77. Merck Female Contraceptives Product Offered
Table 78. Merck Main Business
Table 79. Merck Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Merck Latest Developments
Table 81. Johnson & Johnson Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 82. Johnson & Johnson Female Contraceptives Product Offered
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Johnson & Johnson Latest Developments
Table 86. Lupin Pharmaceuticals Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 87. Lupin Pharmaceuticals Female Contraceptives Product Offered
Table 88. Lupin Pharmaceuticals Main Business
Table 89. Lupin Pharmaceuticals Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Lupin Pharmaceuticals Latest Developments
Table 91. Female Health Company Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 92. Female Health Company Female Contraceptives Product Offered
Table 93. Female Health Company Main Business
Table 94. Female Health Company Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Female Health Company Latest Developments
Table 96. Fuji Latex Details, Company Type, Female Contraceptives Area Served and Its Competitors
Table 97. Fuji Latex Female Contraceptives Product Offered
Table 98. Fuji Latex Main Business
Table 99. Fuji Latex Female Contraceptives Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Fuji Latex Latest Developments
List of Figures
Figure 1. Female Contraceptives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Female Contraceptives Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Female Contraceptives Market Size Market Share by Type in 2021
Figure 7. Female Contraceptives in Personal use
Figure 8. Global Female Contraceptives Market: Personal use (2017-2022) & ($ Millions)
Figure 9. Female Contraceptives in Hospital
Figure 10. Global Female Contraceptives Market: Hospital (2017-2022) & ($ Millions)
Figure 11. Global Female Contraceptives Market Size Market Share by Application in 2021
Figure 12. Global Female Contraceptives Revenue Market Share by Player in 2021
Figure 13. Global Female Contraceptives Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Female Contraceptives Market Size 2017-2022 ($ Millions)
Figure 15. APAC Female Contraceptives Market Size 2017-2022 ($ Millions)
Figure 16. Europe Female Contraceptives Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Female Contraceptives Market Size 2017-2022 ($ Millions)
Figure 18. Americas Female Contraceptives Value Market Share by Country in 2021
Figure 19. Americas Female Contraceptives Consumption Market Share by Type in 2021
Figure 20. Americas Female Contraceptives Market Size Market Share by Application in 2021
Figure 21. United States Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Female Contraceptives Market Size Market Share by Region in 2021
Figure 26. APAC Female Contraceptives Market Size Market Share by Application in 2021
Figure 27. China Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Female Contraceptives Market Size Market Share by Country in 2021
Figure 34. Europe Female Contraceptives Market Size Market Share by Type in 2021
Figure 35. Europe Female Contraceptives Market Size Market Share by Application in 2021
Figure 36. Germany Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Female Contraceptives Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Female Contraceptives Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Female Contraceptives Market Size Market Share by Application in 2021
Figure 44. Egypt Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Female Contraceptives Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 50. APAC Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 51. Europe Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 53. United States Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 54. Canada Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 57. China Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 58. Japan Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 59. Korea Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 61. India Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 62. Australia Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 63. Germany Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 64. France Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 65. UK Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 66. Italy Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 67. Russia Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 68. Spain Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 71. Israel Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Female Contraceptives Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Female Contraceptives Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
